mRNA vaccines — a new era in vaccinology

Pardi, Norbert, Hogan, Michael J., Porter, Frederick W., Weissman, Drew·2018·Nature Reviews Drug Discovery

Cited by (1,011)

Items 501–600 of 1,011

  1. Fluorinated Lipid Nanoparticles for Enhancing mRNA Delivery Efficiency
    Huipeng Zhang, Chaoyang Meng, Xuewen Yi, Jinpeng Han, Junxia Wang, Feng Liu, Qi Ling, Hongjun Li, Zhen Gu · 2024 · ACS Nano
  2. Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
    Mansanguan, Suyanee, Charunwatthana, Prakaykaew, Piyaphanee, Watcharapong, Dechkhajorn, Wilanee, Poolcharoen, Akkapon, Mansanguan, Chayasin · 2022 · Tropical Medicine and Infectious Disease
  3. Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise
    Mareike Kubinski, Jana Beicht, Thomas H. Gerlach, Asisa Volz, Gerd Sutter, Guus F. Rimmelzwaan · 2020 · Vaccines
  4. Spleen-Targeted mRNA Vaccine Doped with Manganese Adjuvant for Robust Anticancer Immunity In Vivo
    Zijin Luo, Yi Lin, Yanan Meng, Mengyao Li, Hongyu Ren, Haoping Shi, Qiang Cheng, Tuo Wei · 2024 · ACS Nano
  5. Expression Kinetics and Innate Immune Response after Electroporation and LNP-Mediated Delivery of a Self-Amplifying mRNA in the Skin
    Huysmans, Hanne, Zhong, Zifu, De Temmerman, Joyca, Mui, Barbara L., Tam, Ying K., Mc Cafferty, Séan, Gitsels, Arlieke, Vanrompay, Daisy, Sanders, Niek N. · 2019 · Molecular Therapy - Nucleic Acids
  6. A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
    Shahad Saif Khandker, Brian Godman, Md. Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md. Ahsanul Haq, Jaykaran Charan, Ali Azam Talukder, Nafisa Azmuda et al. · 2021 · Vaccines
  7. Potential Application of Exosomes in Vaccine Development and Delivery
    Md Nurul Huda, Md Nurunnabi · 2022 · Pharmaceutical Research
  8. Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE—An Observational Study
    Subhashini Ganesan, Latifa Baynouna AlKetbi, Nawal Ahmed Mohamed Al Kaabi, Mohammed Al Mansoori, Noura Nasser Al Maskari, Mariam Saif AlShamsi, Aysha Saeed Alderei, Hamada Nasser El Eissaee, Rudina Mubarak AlKetbi, Noura AlShamsi et al. · 2022 · Frontiers in Public Health
  9. An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates
    Manon Ripoll, Marie‐Clotilde Bernard, Céline Vaure, Emilie Bazin, Sylvie Commandeur, Vladimir Perkov, Katia Lemdani, Marie‐Claire Nicolaï, Patrick Bonifassi, Antoine Kichler et al. · 2022 · Biomaterials
  10. Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems
    Adam M. Weiss, Samir Hossainy, Stuart J. Rowan, Jeffrey A. Hubbell, Aaron Palmer Esser-Kahn · 2022 · Macromolecules
  11. Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery
    Lara M. Mollé, Cameron H. Smyth, Daniel Yuen, Angus P. R. Johnston · 2022 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  12. Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
    Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, Bindra Patel, Anup Kumar, Sanjay Kumar Prasad, Bibhuti Bhusan Kakoti, Ajeet Kumar Kaushik, Mariya Jesawadawala · 2023 · Vaccines
  13. Multifunctional lipid-based nanoparticles for wound healing and antibacterial applications: A review
    Fezile Motsoene, Heidi Abrahamse, Sathish Sundar Dhilip Kumar · 2023 · Advances in Colloid and Interface Science
  14. Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells
    Rein Verbeke, Ine Lentacker, Karine Breckpot, J. Janssens, Serge Van Calenbergh, Stefaan C. De Smedt, Heleen Dewitte · 2019 · ACS Nano
  15. Targets and strategies for vaccine development against SARS-CoV-2
    Jonaid Ahmad Malik, Almas Hanif Mulla, Tahmeena Farooqi, Faheem Hyder Pottoo, Sirajudheen Anwar, Kannan R. R. Rengasamy · 2021 · Biomedicine & Pharmacotherapy
  16. Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
    Katherine L. Mallory, Justin A. Taylor, Xiaoyan Zou, Ishita N. Waghela, Cosette G. Schneider, Michael Q. Sibilo, Neeraja M. Punde, Leah Perazzo, Tatyana Savransky, Martha Sedegah et al. · 2021 · npj Vaccines
  17. Perinatal SARS-CoV-2 Infection and Neonatal COVID-19: A 2021 Update
    Deepika Sankaran, Natasha A. Nakra, Ritu Cheema, Dean A. Blumberg, Satyan Lakshminrusimha · 2021 · NeoReviews
  18. Vaccine development: Current trends and technologies
    Renu Poria, Deepak Kala, Rupak Nagraik, Yashika Walia, Sunny Dhir, Bharat Singh, Naveen Kumar Kaushik, Md Salik Noorani, Ankur Kaushal, Shagun Gupta · 2023 · Life Sciences
  19. Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles
    Douglas W. Brown, Ping Wee, Prakash Bhandari, Amirali B. Bukhari, Liliya Grin, Héctor Vega, Maryam Hejazi, Deborah L. Sosnowski, Jailal Ablack, Eileen K. Clancy et al. · 2024 · Cell
  20. RNA delivery biomaterials for the treatment of genetic and rare diseases
    Zhao, Weiyu, Hou, Xucheng, Vick, Olivia G., Dong, Yizhou · 2019 · Biomaterials
  21. Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries
    Ali J. Marian · 2020 · Cardiovascular Pathology
  22. Role of Ionizable Lipids in SARS-CoV-2 Vaccines As Revealed by Molecular Dynamics Simulations: From Membrane Structure to Interaction with mRNA Fragments
    Markéta Paloncýová, Petra Čechová, Martin Šrejber, Petra Kührová, Michal Otyepka · 2021 · The Journal of Physical Chemistry Letters
  23. Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery
    Hanwen Zhang, Xuexiang Han, Mohamad‐Gabriel Alameh, Sarah J. Shepherd, Marshall Scott Padilla, Lulu Xue, Kamila Butowska, Drew Weissman, Michael J. Mitchell · 2022 · Journal of Biomedical Materials Research Part A
  24. Clinical development and approval of COVID-19 vaccines
    Ulrich Kalinke, Dan H. Barouch, Ruben Rizzi, Eleni Lagkadinou, Özlem Türeci, Shanti Pather, Pieter Neels · 2022 · Expert Review of Vaccines
  25. Current and future direction in treatment of HPV-related cervical disease
    Niloofar Khairkhah, Azam Bolhassani, Reza Najafipour · 2022 · Journal of Molecular Medicine
  26. Safety & effectiveness of COVID-19 vaccines
    Francesco Chirico, Jaime A. Teixeira da Silva, Panagiotis Tsigaris, Khan Sharun · 2022 · The Indian Journal of Medical Research
  27. mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
    Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, Shruti Soni, Avinash D. Khadela, Jinal Ajabiya · 2022 · Vaccines
  28. Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
    Matthew Pine, Gunjan Arora, Thomas M. Hart, Emily Bettini, Brian T. Gaudette, Hiromi Muramatsu, István Tombácz, Taku Kambayashi, Ying K. Tam, Dustin Brisson et al. · 2023 · Molecular Therapy
  29. A comprehensive comparison of DNA and RNA vaccines
    Chunxi Wang, Fan Yuan · 2024 · Advanced Drug Delivery Reviews
  30. Development of mRNA vaccines against respiratory syncytial virus (RSV)
    Xirui Qiu, Siyan Xu, Yang Lu, Zichen Luo, Yang‐Tian Yan, Chuyue Wang, Jianjian Ji · 2022 · Cytokine & Growth Factor Reviews
  31. ROS-Responsive Nanoparticle Delivery of mRNA and Photosensitizer for Combinatorial Cancer Therapy
    Hui Zhou, Yuqin Liao, Xiangfei Han, Dean Shuailin Chen, Xuechuan Hong, Kun Zhou, Xingya Jiang, Yuling Xiao, Jinjun Shi · 2023 · Nano Letters
  32. Advanced technologies for the development of infectious disease vaccines
    Akash Gupta, Arnab Rudra, Kaelan Reed, Róbert Langer, Daniel G. Anderson · 2024 · Nature Reviews Drug Discovery
  33. Enterovirus A71 Vaccines
    Mei-Ling Li, Shin‐Ru Shih, Blanton S. Tolbert, Gary Brewer · 2021 · Vaccines
  34. mRNA in cancer immunotherapy: beyond a source of antigen
    Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Y. Vermaelen, Karine Breckpot, Sandra Van Lint · 2021 · Molecular Cancer
  35. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
    Tim F. Greten, Ghassan K. Abou‐Alfa, Ann‐Lii Cheng, Austin G. Duffy, Anthony B. El-Khoueiry, Richard S. Finn, Peter R. Galle, Lipika Goyal, Aiwu Ruth He, Ahmed Omar Kaseb et al. · 2021 · Journal for ImmunoTherapy of Cancer
  36. COVID-19 Vaccines: An Overview of Different Platforms
    Dmitry Anatolievich Kudlay, Andrey А. Svistunov · 2022 · Bioengineering
  37. Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates
    Yuta Suzuki, Takayuki Miyazaki, Hiroki Muto, Kenji Kubara, Yohei Mukai, Ryuji Watari, Shinya Sato, Keita Kondo, Shin‐ichi Tsukumo, Koji Yasutomo et al. · 2022 · Molecular Therapy — Nucleic Acids
  38. Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells
    Marco Künzli, Stephen D. O’Flanagan, Madeleine LaRue, Poulami Talukder, Thamotharampillai Dileepan, James Michael Stolley, Andrew G. Soerens, Clare F. Quarnstrom, Sathi Wijeyesinghe, Yanqi Ye et al. · 2022 · Science Immunology
  39. Understanding the Barriers and Attitudes toward Influenza Vaccine Uptake in the Adult General Population: A Rapid Review
    Verna Welch, Tom Metcalf, Richard Macey, Kristen J. Markus, Amy J. Sears, Ashley Enstone, Jakob Langer, Amit K. Srivastava, Alejandro D. Cane, Timothy Lee Wiemken · 2023 · Vaccines
  40. Stimuli‐Responsive Nanotechnology for RNA Delivery
    Hui Zhou, Dean Shuailin Chen, Caleb J. Hu, Xuechuan Hong, Jinjun Shi, Yuling Xiao · 2023 · Advanced Science
  41. mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
    Sittplangkoon, Chutamath, Alameh, Mohamad-Gabriel, Weissman, Drew, Lin, Paulo J. C., Tam, Ying K., Prompetchara, Eakachai, Palaga, Tanapat · 2022 · Frontiers in Immunology
  42. Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
    Iman Mohammed Alfagih, Basmah Nasser Aldosari, Bushra T. AlQuadeib, Alanood S. Almurshedi, Mariyam M. Alfagih · 2020 · Pharmaceutics
  43. Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
    Dhruv Bansal, Melissa Andrea Reimers, Eric Marshall Knoche, Russell Kent Pachynski · 2021 · Cancers
  44. HIV mRNA Vaccines—Progress and Future Paths
    Zekun Mu, Barton F. Haynes, Derek W. Cain · 2021 · Vaccines
  45. Chlamydia trachomatis: Cell biology, immunology and vaccination
    Sam M. Murray, Paul F. McKay · 2021 · Vaccine
  46. Ocular adverse events following vaccination: overview and update
    John Yu Cheng, Curtis Edward Margo · 2021 · Survey of Ophthalmology
  47. Current view on novel vaccine technologies to combat human infectious diseases
    Zrinka Matić, Maja Šantak · 2021 · Applied Microbiology and Biotechnology
  48. Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo
    Lili Cui, Morag Rose Hunter, Silvia Sonzini, Sara G. T. Pereira, Steven M. Romanelli, Kai Liu, Weimin Li, Lihuan Liang, Bin Yang, Najet Mahmoudi et al. · 2021 · Small
  49. Deep generative models design mRNA sequences with enhanced translational capacity and stability
    He Zhang, Hailong Liu, Yushan Xu, Haoran Huang, Yiming Liu, Jia Wang, Yan Qin, Haiyan Wang, Lili Ma, Zhiyuan Xun et al. · 2025 · Science
  50. The Quest for a Truly Universal Influenza Vaccine
    Yo Han Jang, Baik Lin Seong · 2019 · Frontiers in Cellular and Infection Microbiology
  51. RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
    Jonas B. Sandbrink, Robin J. Shattock · 2020 · Frontiers in Immunology
  52. You Are What You Assess: The Case for Emphasizing Chemistry on Chemistry Assessments
    Ryan L. Stowe, Leah J. Scharlott, Vanessa R. Ralph, Nicole M. Becker, Melanie M. Cooper · 2021 · Journal of Chemical Education
  53. Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates
    Tomer Zohar, Jeff C. Hsiao, Nickita Mehta, Jishnu Das, Anush Devadhasan, Wiktor Karpinski, Cheryl Callahan, Michael P. Citron, Daniel J. DiStefano, Sinoeun Touch et al. · 2021 · Cell Host & Microbe
  54. mRNA vaccines: the most recent clinical applications of synthetic mRNA
    Suji Kwon, Minseon Kwon, Seongeun Im, Kyuri Lee, Hyukjin Lee · 2022 · Archives of Pharmacal Research
  55. Emerging delivery approaches for targeted pulmonary fibrosis treatment
    Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, Md Nurunnabi · 2023 · Advanced Drug Delivery Reviews
  56. mRNA vaccine sequence and structure design and optimization: Advances and challenges
    Lei Jin, Yuanzhe Zhou, Sicheng Zhang, Shi‐Jie Chen · 2024 · Journal of Biological Chemistry
  57. Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles
    Hanzey Yasar, Alexander Biehl, Chiara De Rossi, Marcus Koch, Xabier Murgia, Brigitta Loretz, Claus‐Michael Lehr · 2018 · Journal of Nanobiotechnology
  58. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy
    Elisheva D. Shanes, Sebastian Otero, Leena Bhattacharya Mithal, Chiedza Mupanomunda, Emily Stinnett Miller, Jeffery A. Goldstein · 2021 · Obstetrics and Gynecology
  59. Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach
    Chang-Gon Kim, Yun Beom Sang, Ji Hyun Lee, Hong Jae Chon · 2021 · International Journal of Molecular Sciences
  60. Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages
    Hanieh Moradian, Toralf Roch, Larissa Anthofer, Andreas Lendlein, Manfred Gossen · 2022 · Molecular Therapy — Nucleic Acids
  61. Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
    Christin Schmidt, Barbara S. Schnierle · 2023 · Pathogens
  62. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
    Jiawei Zeng, Yao Li, Linrui Jiang, Ling Luo, Yue Wang, Hao Wang, Xiaonan Han, Jian Zhao, Guanglei Gu, Min Fang et al. · 2023 · Emerging Microbes & Infections
  63. Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach
    Dhivya Sridaran, Elliot Bradshaw, Carl J. DeSelm, Russell Kent Pachynski, Kiran N. Mahajan, Nupam P. Mahajan · 2023 · Cell Reports Medicine
  64. mRNA Cancer Vaccines: Construction and Boosting Strategies
    Xiaoqing Liu, Pei Huang, Rusen Yang, Hongzhang Deng · 2023 · ACS Nano
  65. Advances in the design and development of SARS-CoV-2 vaccines
    Xue‐Liang Peng, Ji‐Si‐Yu Cheng, Hai‐Lun Gong, Meng-Di Yuan, Xiaohong Zhao, Zibiao Li, Dai‐Xu Wei · 2021 · Military Medical Research
  66. Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines
    Irene Fernández‐Delgado, Diego Calzada‐Fraile, Francisco Sánchez‐Madrid · 2020 · Cancers
  67. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
    Qingrui Huang, Kai Ji, Siyu Tian, Fengze Wang, Baoying Huang, Zhou Tong, Shuguang Tan, Junfeng Hao, Qihui Wang, Wenjie Tan et al. · 2021 · Nature Communications
  68. Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases
    Damien van de Berg, Zoltán Kis, Carl Fredrik Behmer, Karnyart Samnuan, Anna K. Blakney, Cleo Kontoravdi, Robin J. Shattock, Nilay Shah · 2021 · npj Vaccines
  69. The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
    Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, Vinícius Couto Pires, Luis Alberto Breda Mascarenhas, Leone Peter Correia da Silva Andrade, Marcelo Albano Moret, Roberto José da Silva Badaró · 2022 · Vaccines
  70. mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
    Kosuke Sasaki, Yusuke Sato, Kento Okuda, Kazuki Iwakawa, Hideyoshi Harashima · 2022 · Pharmaceutics
  71. Nanopore sequencing technology and its applications
    Peijie Zheng, Chuntao Zhou, Yuemin Ding, Bin Liu, Liuyi Lu, Feng Zhu, Shiwei Duan · 2023 · MedComm
  72. Comprehensive Impurity Profiling of mRNA: Evaluating Current Technologies and Advanced Analytical Techniques
    Julien Camperi, Steffen Lippold, Luladey Ayalew, Brian Roper, Stephanie Shao, Emily C. Freund, Ariane Nissenbaum, Carolina Galan, Qinjingwen Cao, Feng Yang et al. · 2024 · Analytical Chemistry
  73. Self-Amplifying RNA Approach for Protein Replacement Therapy
    Papukashvili, Dimitri, Rcheulishvili, Nino, Liu, Cong, Ji, Yang, He, Yunjiao, Wang, Peng George · 2022 · International Journal of Molecular Sciences
  74. Oligonucleotide Phosphorothioates Enter Cells by Thiol‐Mediated Uptake
    Quentin Laurent, Rémi Martinent, Dimitri Moreau, Nicolas Winssinger, Naomi Sakai, Stefan Matile · 2021 · Angewandte Chemie International Edition
  75. Enhanced photocatalytic activity and antiviral evaluation of CuO@Fe2O3 NC for amoxicillin degradation and SARS-CoV-2 treatment
    Souheila Legmairi, Souhaila Meneceur, Gamil Gamal Hasan, Laouini Salah Eddine, Hamdi Ali Mohammed, Fahad A. Alharthi, Johar Amin Ahmed Abdullah · 2023 · Nanotechnology
  76. Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies
    Xiaonan Huang, Yishan Ma, Guanghui Ma, Yufei Xia · 2024 · Research
  77. Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
    Saber İmani, Xiaoyan Li, Keyi Chen, Mazaher Maghsoudloo, Parham Jabbarzadeh Kaboli, Mehrdad Hashemi, Saloomeh Khoushab, Xiaoping Li · 2025 · Frontiers in Cellular and Infection Microbiology
  78. Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
    Tay, Ban Qi, Wright, Quentin, Ladwa, Rahul, Perry, Christopher, Leggatt, Graham, Simpson, Fiona, Wells, James W., Panizza, Benedict J., Frazer, Ian H., Cruz, Jazmina L. G. · 2021 · Vaccines
  79. Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections
    Sabrina Schrauf, Roland Tschismarov, Erich Tauber, Katrin Ramsauer · 2020 · Frontiers in Immunology
  80. Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
    Nuphar Veiga, Yael Diesendruck, Dan Peer · 2020 · Advanced Drug Delivery Reviews
  81. Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
    Hannah M. Kelly, Brent S. Sokola, Hesham Abboud · 2021 · Journal of Neuroimmunology
  82. Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy
    DaeYong Lee, Kristin Michelle Huntoon, Yifan Wang, Wen Jiang, Betty Y.S. Kim · 2021 · Advanced Materials
  83. iCodon customizes gene expression based on the codon composition
    Michay Diez, Santiago Gerardo Medina-Muñoz, Luciana Andrea Castellano, Gabriel da Silva Pescador, Qiushuang Wu, Ariel Bazzini · 2022 · Scientific Reports
  84. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
    Dapeng Li, David R. Martinez, Alexandra Schäfer, Haiyan Chen, Maggie Barr, Laura L. Sutherland, Esther Lee, Robert Parks, Dieter Mielke, Whitney Edwards et al. · 2022 · Nature Communications
  85. mRNA therapeutics: New vaccination and beyond
    Huanhuan Y. Wei, Liangliang Zheng, Zefeng Wang · 2023 · Fundamental Research
  86. Progress and prospects on vaccine development against monkeypox infection
    Mohamed Jamal Saadh, Tahmineh Ghadimkhani, Narges Soltani, Arian Abbassioun, Renzon Daniel Cosme Pecho, Ali taha, Tareq Jwad Kazem, Saman Yasamineh, Omid Gholizadeh · 2023 · Microbial Pathogenesis
  87. Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects
    Rao Fu, Ruoyao Qi, Hualong Xiong, Xing Lei, Yao Jiang, Jinhang He, Feng Chen, Liang Zhang, Dekui Qiu, Yiyi Chen et al. · 2024 · Signal Transduction and Targeted Therapy
  88. Innate immune responses against mRNA vaccine promote cellular immunity through IFN-β at the injection site
    Seongryong Kim, Ji Hyang Jeon, Myeonghwan Kim, Yeji Lee, Yun-Ho Hwang, Myungsun Park, C. Han Li, Taeyoung Lee, Jung-Ah Lee, You‐Me Kim et al. · 2024 · Nature Communications
  89. One Size Does Not Fit All: The Effect of Chain Length and Charge Density of Poly(ethylene imine) Based Copolymers on Delivery of pDNA, mRNA, and RepRNA Polyplexes
    Anna K. Blakney, Gökhan Yilmaz, Paul F. McKay, C. Remzi Becer, Robin J. Shattock · 2018 · Biomacromolecules
  90. UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION: A Possible Association.
    Tamar Rabinovitch, Yael Ben‐Arie‐Weintrob, Tamar Hareuveni‐Blum, Boaz Shaer, Vicktoria Vishnevskia‐Dai, Shiri Shulman, Hadas Newman, Muhammad Biadsy, Dua Masarwa, Naomi Fischer et al. · 2021 · PubMed
  91. Current Status of COVID‐19 (Pre)Clinical Vaccine Development
    Tingting Ye, Zifu Zhong, Adolfo García‐Sastre, Michael Schotsaert, Bruno G. De Geest · 2020 · Angewandte Chemie International Edition
  92. Cell and tissue engineering in lymph nodes for cancer immunotherapy
    Alexander J. Najibi, David J. Mooney · 2020 · Advanced Drug Delivery Reviews
  93. Polymer–Lipid Hybrid Materials
    Yoo Kyung Go, Cecília Leal · 2021 · Chemical Reviews
  94. Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
    Fatemeh Davodabadi, Mohammad Sarhadi, Javad Arabpour, Saman Sargazi, Abbas Rahdar, Ana Maria Diez-Pascual · 2022 · Journal of Controlled Release
  95. Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNA
    Xijun Piao, Vibha Yadav, Eddie Wang, Wayne Chang, Lanna Tau, Benjamin E. Lindenmuth, Sharon Xuesong Wang · 2022 · Molecular Therapy — Nucleic Acids
  96. Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections
    Mena Hajiaghapour Asr, Fatemeh Dayani, Fatemeh Saedi Segherloo, Ali Kamedi, Andrew O’ Neill, Ronan J. MacLoughlin, Mohammad Doroudian · 2023 · Pharmaceutics
  97. The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
    Zhongfeng Ye, Joseph Harmon, Wei Ni, Yamin Li, Douglas Wich, Qiaobing Xu · 2023 · ACS Nano
  98. Cancer vaccines in the clinic
    Morgan Elizabeth Janes, Alexander P. Gottlieb, Kyong Soo Park, Zongmin Zhao, Samir Mitragotri · 2023 · Bioengineering & Translational Medicine
  99. Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape
    Matilde Durán‐Lobato, Ana M. López-Estévez, Ana Sara Cordeiro, Tamara G. Dacoba, José Crecente‐Campo, Dolores Torres, Marı́a José Alonso · 2021 · Advanced Drug Delivery Reviews
  100. Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
    Hua Zhong, Shuai Liu, Fang Cao, Yi Zhao, Jian‐Guo Zhou, Feng Ru Tang, Zhaohua Peng, Yangsheng Li, Shen Xu, Chunlin Wang et al. · 2021 · Frontiers in Immunology